Retraction: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells, (IUBMB Life, (2015), 67, (380–394), 10.1002/iub.1381);MiR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells

IUBMB Life

Volumn 67, Issue 5, 2015, Pages 380-394

  Zhao, Jian Li ^a   Zhang, Le ^a   Guo, Xu ^a   Wang, Jing Hua ^a   Zhou, Wen ^a   Liu, Min ^a   Li, Xin ^a   Tang, Hua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

cervical cancer; EMT; miR 212 132; miRNA; SMAD2

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; MICRORNA 132; MICRORNA 212; SMAD2 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; MICRORNA; MIRN132 MICRORNA, HUMAN; MIRN212 MICRORNA, HUMAN; SMAD2 PROTEIN, HUMAN;

ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL CYCLE; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PROTEIN EXPRESSION; TUMOR INVASION; UTERINE CERVIX CANCER; CELL CYCLE G1 PHASE; HELA CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; UTERINE CERVIX TUMOR;

DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; G1 PHASE; HELA CELLS; HUMANS; MICRORNAS; S PHASE; SMAD2 PROTEIN; UTERINE CERVICAL NEOPLASMS;

EID: 84930198106     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.2815     Document Type: Erratum

References (37)

1. zur Hausen, H., (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.
2. Deftereos, G., Corrie, S. R., Feng, Q., Morihara, J., Stern, J., et al., (2011) Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer. PLoS One 6, e28423.
3. Bartel, D. P., (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Yao, Q., Xu, H., Zhang, Q. Q., Zhou, H., and, Qu, L. H., (2009) MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem. Biophys. Res. Commun. 388, 539-542.
5. Yao, T., and, Lin, Z., (2012) MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim. Biophys. Acta 1822, 248-260.
6. Long, M. J., Wu, F. X., Li, P., Liu, M., Li, X., et al., (2012) MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells. Cancer Lett. 324, 186-196.
7. Cui, F., Li, X., Zhu, X., Huang, L., Huang, Y., et al., (2012) MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cell. Physiol. Biochem. 30, 1310-1318.
8. Wong, H. K., Veremeyko, T., Patel, N., Lemere, C. A., Walsh, D. M., et al., (2013) De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Hum. Mol. Genet. 22, 3077-3092.
9. Godoy, J., Nishimura, M., and, Webster, N. J., (2011) Gonadotropin-releasing hormone induces miR-132 and miR-212 to regulate cellular morphology and migration in immortalized LβT2 pituitary gonadotrope cells. Mol. Endocrinol. 25, 810-820.
10. Park, J. K., Henry, J. C., Jiang, J., Esau, C., Gusev, Y., et al., (2011) MiR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor. Biochem. Biophys. Res. Commun. 406, 518-523.
11. Miyazono, K., Suzuki, H., and, Imamura, T., (2003) Regulation of TGF-β signaling and its roles in progression of tumors. Cancer Sci. 94, 230-234.
12. Massague, J., (2008) TGFβ in cancer. Cell 134, 215-230.
13. Massague, J., Seoane, J., and, Wotton, D., (2005) Smad transcription factors. Genes Dev. 19, 2783-2810.
14. Derynck, R., and, Zhang, Y. E., (2003) Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 425, 577-584.
15. Derynck, R., Akhurst, R. J., and, Balmain, A., (2001) TGF-β signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
16. Louafi, F., Martinez-Nunez, R. T., and, Sanchez-Elsner, T., (2010) MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J. Biol. Chem. 285, 41328-41336.
17. Liu, X., Song, L., Liu, J., Wang, S., Tan, X., et al., (2013) MiR-18b inhibits TGF-β1-induced differentiation of hair follicle stem cells into smooth muscle cells by targeting SMAD2. Biochem. Biophys. Res. Commun. 438, 551-556.
18. Bao, Y., Chen, Z., Guo, Y., Feng, Y., Li, Z., et al., (2014) Tumor suppressor microRNA-27a in colorectal carcinogenesis and progression by targeting SGPP1 and Smad2. PLoS One 9, e105991.
19. Qiang, R., Wang, F., Shi, L. Y., Liu, M., Chen, S., et al., (2011) Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 43, 632-641.
20. Osaki, M., Takeshita, F., and, Ochiya, T., (2008) MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 13, 658-670.
21. Wang, J., Xu, G., Shen, F., and, Kang, Y., (2014) MiR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells. Tumour Biol. 35, 4859-4865.
22. You, J., Li, Y., Fang, N., Liu, B., Zu, L., et al., (2014) MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2. PLoS One 9, e91827.
23. Incoronato, M., Garofalo, M., Urso, L., Romano, G., Quintavalle, C., et al., (2010) MiR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 70, 3638-3646.
24. Anand, S., Majeti, B. K., Acevedo, L. M., Murphy, E. A., Mukthavaram, R., et al., (2010) MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 16, 909-914.
25. Lee, M. Y., and, Shen, M. R., (2012) Epithelial-mesenchymal transition in cervical carcinoma. Am. J. Transl. Res. 4, 1-13.
26. Cano, A., Perez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., et al., (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2, 76-83.
27. Bolos, V., Peinado, H., Perez-Moreno, M. A., Fraga, M. F., Esteller, M., et al., (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci. 116, 499-511.
28. Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., et al., (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927-939.
29. Fukuchi, M., Nakajima, M., Miyazaki, T., Masuda, N., Osawa, H., et al., (2006) Lack of activated Smad2 in transforming growth factor-β signaling is an unfavorable prognostic factor in patients with esophageal squamous cell carcinoma. J. Surg. Oncol. 94, 51-56.
30. Xie, W., Mertens, J. C., Reiss, D. J., Rimm, D. L., Camp, R. L., et al., (2002) Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res. 62, 497-505.
31. Xie, W., Rimm, D. L., Lin, Y., Shih, W. J., and, Reiss, M., (2003) Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J. 9, 302-312.
32. Shinto, O., Yashiro, M., Toyokawa, T., Nishii, T., Kaizaki, R., et al., (2010) Phosphorylated smad2 in advanced stage gastric carcinoma. BMC Cancer 10, 652.
33. Papageorgis, P., Lambert, A. W., Ozturk, S., Gao, F., Pan, H., et al., (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 70, 968-978.
34. Zhao, B. M., and, Hoffmann, F. M., (2006) Inhibition of transforming growth factor-β1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA. Mol. Biol. Cell 17, 3819-3831.
35. He, Z., Jiang, J., Kokkinaki, M., and, Dym, M., (2009) Nodal signaling via an autocrine pathway promotes proliferation of mouse spermatogonial stem/progenitor cells through Smad2/3 and Oct-4 activation. Stem Cells 27, 2580-2590.
36. Sengupta, S., Jana, S., and, Bhattacharyya, A., (2014) TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells. Cell. Signal. 26, 240-252.
37. Kloth, J. N., Kenter, G. G., Spijker, H. S., Uljee, S., Corver, W. E., et al., (2008) Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival. Mod. Pathol. 21, 866-875.